XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel · Delayed Price · Currency is ILS · Price in ILA 5.20
0.00 (0.00%)
Jul 17, 2025, 5:24 PM IDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of 45.83 million as of July 18, 2025. Its market cap has decreased by -3.32% in one year.
Market Cap
45.83M
Enterprise Value
42.17M
Revenue
1.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.20
Market Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 45.83M, a decrease of -94.31%. That is a compound annual growth rate of -13.42%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 61.63B |
| Danel (Adir Yeoshua) | 2.90B |
| Kamada | 1.47B |
| Bait Bakfar | 1.07B |
| SofWave Medical | 841.86M |
| BrainsWay | 766.86M |
| Novolog (Pharm-Up 1966) | 717.73M |
| Ilex Medical | 662.22M |